People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $352.5M | $2.8B | 2020 |
Rui Zhu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rui Zhu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Judith Li | 1 | 8 |
| Simeon George | 1 | 8 |
| Chen Yu | 1 | 7 |
| Erez Chimovits | 1 | 7 |
| Lorence Kim | 1 | 5 |
| Sheila Gujrathi | 1 | 5 |
| Hongbo Lu | 1 | 4 |
| Yuan Sun | 1 | 1 |
| Zhen Li | 1 | 1 |
| Yuan (Eliza) Sun | 1 | 1 |
| Ricky Sun | 1 | 1 |
| Xiong Zhang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.